Skip to content

Prognosis of a First-Ever Stroke in Persons Living With HIV

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02748252
Acronym
PROFES
Enrollment
4
Registered
2016-04-22
Start date
2015-12-31
Completion date
2016-12-31
Last updated
2018-08-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebrovascular Accident, Acute, HIV

Brief summary

With aging of the persons living with HIV, cardiovascular diseases now account for substantial mortality and morbidity. Stroke frequency grows exponentially with aging and its incidence doubles every decade over 55 years of age. The prognosis of ischemic stroke depends mainly on the care in Stroke Units in the acute phase of the disease (thrombolysis/thrombectomy). It is important that HIV patients are referred to these units in the first hours of a stroke and not to their infectious disease units which is a loss of chance. It would also be important to know whether HIV patients need specific protocols for stroke emergency management. The study aims to compare the functional prognosis after the first occurrence of an ischemic stroke, in patients admitted to a Stroke Unit, whether they are infected or not infected by HIV.

Interventions

OTHERstroke center referral

Sponsors

Fondation Ophtalmologique Adolphe de Rothschild
Lead SponsorNETWORK

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients unexposed to HIV: HIV-1 seronegative OR patients exposed to HIV: HIV seropositive for over 6 months with or without antiretroviral treatment. Confirmed by Elisa and Western blot tests * admitted for ischemic stroke, defined as a sudden cerebrovascular event confirmed by MRI * at least 18 years of age * paired with patients unexposed to HIV, admitted for ischemic stroke, same gender and age

Exclusion criteria

* antecedents of a symptomatic ischemic or hemorrhagic cerebrovascular event * no social security benefits; * Absence of signed informed consent for the study * Patients currently pregnant or breast-feeding

Design outcomes

Primary

MeasureTime frame
degree of disability measured with the modified Rankin Scale3 months

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026